Omiya, Japan

Masakazu Fujita

This inventor holds 2 USPTO granted patents. Top assignee: Nikken Chemicals Co., Ltd.. Active years: 1998-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masakazu Fujita. Retrieved from https://idiyas.com/inventor/masakazu-fujita-1o7basf5

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.1

ph-index = 2

Forward Citations = 49(Granted Patents)


Location History:

  • Urawa, JP (1998)
  • Omiya, JP (2002)

Company Filing History:


Years Active: 1998-2002

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Masakazu Fujita: Innovator in Medicinal Chemistry

Introduction

Masakazu Fujita is a prominent inventor based in Omiya, Japan. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative patents. With a total of 2 patents, Fujita has established himself as a key figure in the pharmaceutical industry.

Latest Patents

Fujita's latest patents include the development of Triazolo-1,4-diazepine compounds and a medicinal composition containing the same. Additionally, he has worked on a 1,4-dihydropyridine compound and its associated pharmaceutical composition. These inventions reflect his commitment to advancing medical science and improving therapeutic options.

Career Highlights

Fujita is currently employed at Nikken Chemicals Co., Ltd., where he continues to innovate and contribute to the field. His work has garnered attention for its potential applications in medicine, showcasing his expertise and dedication to research.

Collaborations

Fujita has collaborated with notable colleagues, including Taketsugu Seki and Tetsuro Sano. These partnerships have further enhanced his research and development efforts, leading to impactful advancements in medicinal chemistry.

Conclusion

Masakazu Fujita's contributions to the field of medicinal chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for new therapeutic solutions in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…